Navigation Links
DURECT Reports Data From European Phase IIb Shoulder Study of POSIDUR™ (SABER™-Bupivacaine) and Amendment of the Nycomed Agreement
Date:2/9/2011

t of that study in the first half of 2011."

POSIDUR

POSIDUR is a long-acting local anesthetic under development by DURECT and Hospira (for the U.S. and Canada) and by DURECT and Nycomed (for Europe and other defined territories) for the treatment of post-surgical pain. It is intended to be administered during surgery, where it continuously releases therapeutic levels of bupivacaine in a controlled fashion, providing up to 72 hours of uninterrupted local analgesia.  POSIDUR's performance is due to DURECT's patented SABER™ delivery system, an injectable, biodegradable drug delivery technology.

About the DURECT / NYCOMED Collaboration

In November 2006, DURECT signed a collaboration agreement with Nycomed, a privately-held international pharmaceutical company headquartered in Switzerland, whereby DURECT has licensed Nycomed the exclusive commercialization rights to POSIDUR in the European Union (E.U.) and select other countries.  This agreement was subsequently amended in February 2010 and in February 2011.    

About DURECT Corporation

DURECT is a specialty pharmaceutical company developing innovative drugs for pain and other chronic diseases, with late-stage development programs including REMOXY®, POSIDUR™, ELADUR™, and TRANSDUR®-Sufentanil.  DURECT's proprietary oral, transdermal and injectable depot delivery technologies may enable new indications and superior clinical/commercial attributes such as abuse deterrence, improved convenience, compliance, efficacy and safety for small molecule and biologic drugs.  For more information, please visit www.durect.com.

NOTE: POSIDUR™, SABER™, ORADUR®, TRANSDUR®, and ELADUR™ are trademarks of DURECT Corporation. Other referenced trademarks belong to their respective owners.  REMOXY, POSIDUR, ELADUR and TRANSDUR-Sufentanil are dru
'/>"/>

SOURCE DURECT Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. DURECT Announces Positive ELADUR(TM) Phase IIa Study Results
2. ELADUR(TM) Development Update: DURECT Receives Orphan Drug Designation for Bupivacaine for Post-Herpetic Neuralgia
3. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
4. DURECT Corporation Invites You to Join its Third Quarter 2009 Earnings Conference Call
5. DURECT to Present at the 21st Annual Piper Jaffray Health Care Conference
6. DURECT Corporation Invites You to Join Its Fourth Quarter 2009 Earnings Conference Call
7. DURECT and Nycomed Amend POSIDUR(TM) License Agreement to Separate Funding and Control of U.S. and E.U. Clinical Programs and to Expand Territory
8. DURECT Corporation Announces Fourth Quarter and Year End 2009 Financial Results
9. DURECT to Present at the Cowen and Company Healthcare Conference
10. DURECT to Present at the Barclays Capital Global Healthcare Conference
11. DURECT Corporation Invites You to Join Its First Quarter 2010 Earnings Conference Call
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire-iReach/ -- Market Research ... Industry, 2009-2019 is a professional and in-depth market ... Scanner industry . The report firstly reviews the ... classification, application and manufacturing technology. The report then ... Crystallography Scanner listing their product specification, capacity, Production ...
(Date:8/29/2014)... 2014  Chuma Holdings, Inc. (OTCBB:CHUM) (the "Company"), ... support services for the lawfully organized cannabis industry, ... approved the Company,s name and symbol change request. ... be known as Chuma Holdings, Inc. ... merger with the Company,s wholly-owned subsidiary, Chuma Holdings, ...
(Date:8/29/2014)... 29, 2014 The clinical and medical insights ... difference between a product,s success or failure. Despite this, ... KOL targets – and then to coordinate activities and ... relationships upon which successful KOL engagement rests. ... identified internal inconsistencies in their KOL management systems and ...
Breaking Medicine Technology:X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 2X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 3X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 4X-Ray Crystallography Scanner Industry For Global and Chinese Market Forecast to 2019 5CannaMed Announces Name Change and Trading Symbol Change 2CannaMed Announces Name Change and Trading Symbol Change 3Implementing a Strategic Thought Leader Management & Engagement System 2
... England and TOKYO, June 29 , ... Sosei Group Corporation ("Sosei"; TSE Mothers ... commencement of a Phase III,clinical study by Novartis, with NVA237, ... obstructive pulmonary disease,(COPD). NVA237 is a dry powder formulation for ...
... and New Genetic Mutations Acting Together-- , , ... autism inheritance puzzle are emerging in the latest study ... Hospital of Philadelphia, the University of Pennsylvania ... identified 27 different genetic regions where rare copy number ...
Cached Medicine Technology:Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 2Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 3Sosei and Vectura Announce Start of Phase III Clinical Study With NVA237 4More Gene Mutations Linked to Autism Risk 2More Gene Mutations Linked to Autism Risk 3More Gene Mutations Linked to Autism Risk 4
(Date:8/30/2014)... In today’s world, a good night’s sleep has become especially ... (a medical problem where the airway collapses during sleep and ... rest they need to face their daily challenges. , ... people in the United States alone have sleep apnea. Of ... those treated, many cannot tolerate their prescribed medical device known ...
(Date:8/30/2014)... Tulsa, OK (PRWEB) August 30, 2014 ... especially valuable, and increasingly difficult to get. Snoring and ... during sleep and breathing stops) robs people and their ... their daily challenges. Up to 45% of the population ... alone have sleep apnea. Of these, only 10% have ...
(Date:8/30/2014)... One of the most recent dietary trends to have ... meant for sufferers of gluten intolerance and celiac disease, the ... looking to get healthier by simply consuming foods which are ... information erroneous, it also exposes those same consumers to ... change in their food consumption habits. , Because ...
(Date:8/30/2014)... August 30, 2014 Top10BestSEOHosting.com is ... researchers have announced that HostGator.com http://secure.hostgator.com/~affiliat/cgi-bin/affiliates/clickthru.cgi?id=seohosts ... current market. Also, they has announced that Bluehost ... , Hostgator, one of the Top 10 ... of cheap Windows hosting, and it offers rich ...
(Date:8/30/2014)... (PRWEB) August 30, 2014 The new review ... program was created by Karen Brimeyer, who wanted to make ... , This guide is now easy to find in ... download. In this guide, the author of the new method ... , Daily Gossip writes in its review that the ...
Breaking Medicine News(10 mins):Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:Snoring: Bad for Relationships, Bad for Health 2Health News:Snoring: Bad for Relationships, Bad for Health 3Health News:“What is Gluten: Three Things You Need to Know Before Adopting a Gluten-Free Diet” Reveals What Readers Need to Know About the Benefits of a Strict Gluten Diet - Vinamy 2Health News:Top10BestSEOHosting.com: HostGator.com Is The Best Windows Hosting Supplier 2Health News:Leaky Gut Cure Review Reveals Unique Method to Stop Chronic Symptoms 2
... Tube-Feeding Best-Practice Recommendations NEW ORLEANS, Feb. 3 ... HealthCare Nutrition and the American Society for Parenteral ... launch of a new initiative to promote safe ... designed to raise awareness of key steps that ...
... LEXINGTON, Ky., Feb. 3 Just because the economy isn,t ... a Valentine,s surprise for that,special someone. Now,s the time ... from discounted treatments to complimentary services. Roses wilt,and chocolates melt, ... not only a,romantic gift but a healthful one too. , ...
... out the bumps in aesthetic skin care with its latest offering. ... the UniForm handpiece, recently approved by the FDA for cellulite treatment. ... ... seeking painless cellulite treatment, New York City based Juva Skin and ...
... (February 2, 2009) New research published in the ... College of Surgeons suggests that a traditional, "open" ... for the majority of patients with acute appendicitis, contrary ... are performed in the United States each year to ...
... Feb. 2 Smith & Nephew,s Advanced Wound ... announced that the U.S. Court of Appeals for the Federal ... 1 negative pressure wound therapy system marketed by Blue Sky ... Sky in May 2007."Smith & Nephew welcomes the appeals court ...
... Living: The Financial Options Guide Now Available at Sunrise ... Senior Living (NYSE: SRZ ) now offers ... families identify ideas for affording senior care in today,s ... Living: The Financial Options , is available at Sunrise ...
Cached Medicine News:Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 2Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 3Health News:Nestle HealthCare Nutrition and Medical Professionals Unite to Improve Patient Safety 4Health News:Rev Up the Romance this Valentine's Day with Savvy Spa Savings 2Health News:Juva Skin Banishes Bumps with New UniForm Cellulite Therapy Handpiece 2Health News:Treating appendicitis by laparoscopic surgery may not be worth the cost 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 2Health News:U.S. Court of Appeals Rules That Smith & Nephew Does Not Infringe KCI Patents 3Health News:Sunrise Senior Living Helps Families Explore Senior Care Financing Options with New Guide 2
Bausch & Lomb magnifiers incorporates precision optics and patented ergonomic designs for increased clarity and comfort during use....
Bausch & Lomb round and rectangular magnifiers incorporate precision optics and an ergonomic design for increased clarity and comfort during use...
... Micro Thin Sheet. Medpor Sheets are ... and other craniofacial applications. The thinner ... provide the surgeon with greater flexibility ... for easy insertion into the orbit. ...
Adjustable piston accommodates 7 - 9 mm trephine blade. Complete punch includes base plate, piston carrier, piston for 7 - 9 mm trephine blades and 18 mm diameter Teflon block. Designed for accurate ...
Medicine Products: